CN111601610A - 使用布劳特氏菌属菌株治疗疾病的组合物和方法 - Google Patents

使用布劳特氏菌属菌株治疗疾病的组合物和方法 Download PDF

Info

Publication number
CN111601610A
CN111601610A CN201880073533.9A CN201880073533A CN111601610A CN 111601610 A CN111601610 A CN 111601610A CN 201880073533 A CN201880073533 A CN 201880073533A CN 111601610 A CN111601610 A CN 111601610A
Authority
CN
China
Prior art keywords
carcinoma
strain
protein
mage
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880073533.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN111601610A8 (zh
Inventor
B.古德曼
H.波尼奇特拉
A.伊塔诺
T.A.科尔马克
M.西佐瓦
V.克拉维茨
E.加夫里什
C.贝斯-詹格雷科
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epiva Biosciences Inc
Original Assignee
Epiva Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epiva Biosciences Inc filed Critical Epiva Biosciences Inc
Publication of CN111601610A publication Critical patent/CN111601610A/zh
Publication of CN111601610A8 publication Critical patent/CN111601610A8/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CN201880073533.9A 2017-11-14 2018-11-14 使用布劳特氏菌属菌株治疗疾病的组合物和方法 Pending CN111601610A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762585782P 2017-11-14 2017-11-14
US62/585782 2017-11-14
PCT/US2018/060998 WO2019099482A1 (en) 2017-11-14 2018-11-14 Compositions and methods for treating disease using a blautia strain

Publications (2)

Publication Number Publication Date
CN111601610A true CN111601610A (zh) 2020-08-28
CN111601610A8 CN111601610A8 (zh) 2023-07-21

Family

ID=64746632

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880073533.9A Pending CN111601610A (zh) 2017-11-14 2018-11-14 使用布劳特氏菌属菌株治疗疾病的组合物和方法

Country Status (7)

Country Link
US (2) US10493113B2 (cg-RX-API-DMAC7.html)
EP (1) EP3710023A1 (cg-RX-API-DMAC7.html)
JP (1) JP2021502964A (cg-RX-API-DMAC7.html)
CN (1) CN111601610A (cg-RX-API-DMAC7.html)
AR (1) AR113881A1 (cg-RX-API-DMAC7.html)
TW (1) TW201936203A (cg-RX-API-DMAC7.html)
WO (1) WO2019099482A1 (cg-RX-API-DMAC7.html)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111712260A (zh) * 2018-01-31 2020-09-25 伊夫罗生物科学公司 使用毛螺菌科细菌治疗免疫病症的组合物和方法
CN114225024A (zh) * 2021-12-29 2022-03-25 北京创世客生物技术有限公司 一种用于治疗疾病的益生菌药物或保健品
CN114806979A (zh) * 2022-06-29 2022-07-29 杭州师范大学附属医院(杭州市第二人民医院) 一种治疗非酒精性脂肪性肝病的益生菌复合物及其应用
CN116254198A (zh) * 2023-01-05 2023-06-13 中国科学院微生物研究所 一种布劳特氏菌及其应用
CN116549465A (zh) * 2023-04-26 2023-08-08 复旦大学附属中山医院 Aldh2小分子激动剂在制备治疗心血管疾病及其代谢性疾病的药物中的应用
CN116867502A (zh) * 2020-09-18 2023-10-10 伊夫罗生物科学公司 细菌的固体剂型
CN117617181A (zh) * 2023-12-27 2024-03-01 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) 一种系统性红斑狼疮小鼠模型的构建方法和应用
CN119709558A (zh) * 2025-02-26 2025-03-28 昆明医科大学第一附属医院(云南省皮肤病医院) 布劳特氏菌emf75-02b1b及其用途

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7217700B2 (ja) 2016-09-13 2023-02-03 アラーガン、インコーポレイテッド 安定化非タンパク質クロストリジウム毒素組成物
EP3518946A4 (en) 2016-09-27 2020-09-09 Board of Regents, The University of Texas System METHODS TO IMPROVE IMMUNE CHECKPOINT BLOCKING TREATMENT BY MODULATING THE MICROBIOME
TW201920648A (zh) * 2017-08-29 2019-06-01 美商艾弗洛生物科技股份有限公司 使用布勞特氏(blautia)菌株治療癌症
CN111601610A (zh) 2017-11-14 2020-08-28 伊夫罗生物科学公司 使用布劳特氏菌属菌株治疗疾病的组合物和方法
CA3176812A1 (en) 2018-07-11 2020-01-16 Actym Therapeutics, Inc. Engineered immunostimulatory bacterial strains and uses thereof
AU2019384816A1 (en) 2018-11-21 2021-06-24 Board Of Regents, The University Of Texas System Methods and compositions for treating cancer
EP3911161A4 (en) * 2019-01-16 2022-09-14 Board of Regents, The University of Texas System METHODS AND COMPOSITIONS FOR THE TREATMENT OF COLITIS-ASSOCIATED IMMUNE CHECKPOINT INHIBITOR
TW202108153A (zh) * 2019-05-10 2021-03-01 英商4D製藥研究有限公司 包含細菌菌株之組成物
JP2022537684A (ja) * 2019-06-11 2022-08-29 エヴェロ バイオサイエンシズ,インコーポレーテッド 分泌された微生物細胞外小胞
CN112442455B (zh) * 2019-09-03 2022-04-01 北京量化健康科技有限公司 具有防治高血脂症功能的布劳特氏菌以及产品组合物及其制备方法和应用
CN111304120B (zh) * 2020-02-24 2021-07-23 浙江大学 Blautia sp B2132菌在预防和/或治疗炎症性肠病中的应用
WO2021242988A1 (en) 2020-05-28 2021-12-02 Trench Therapeutics, Inc. Airway medicaments
TW202214275A (zh) * 2020-06-11 2022-04-16 美商艾弗洛生物科技股份有限公司 使用fournierella massiliensis治療疾病和障礙之組成物及方法
CN115942944A (zh) * 2020-06-11 2023-04-07 伊夫罗生物科学公司 使用颤螺旋菌科微生物胞外囊泡治疗疾病和障碍的组合物和方法
WO2021252861A1 (en) * 2020-06-11 2021-12-16 Evelo Biosciences, Inc. Compositions and methods for treating diseases and disorders using megasphaera sp
CN113842497B (zh) * 2021-09-28 2022-05-17 太原理工大学 一种具有光控抗菌和自愈合功能的CuS@Cur杂化水凝胶敷料的制备方法
US20260165955A1 (en) 2022-03-18 2026-06-18 Meiji Co., Ltd. Composition for controlling growth of bacteria of the genus collinsella and use thereof
US20250205220A1 (en) * 2022-03-31 2025-06-26 Bruce K. Patterson Methods of Treating a Subject for Post-Treatment Lyme Disease (PTLD) and Compositions for Use in the Same
US20250235433A1 (en) * 2022-04-19 2025-07-24 Cedars-Sinai Medical Center Methods of treating and diagnosing fatty liver disease
JP7706190B2 (ja) * 2023-09-25 2025-07-11 オルト株式会社 ブラウティア属細菌
JP7706191B2 (ja) * 2023-09-25 2025-07-11 オルト株式会社 ブラウティア属細菌を用いた免疫賦活剤
WO2025070283A1 (ja) * 2023-09-25 2025-04-03 オルト株式会社 ブラウティア属細菌を用いた免疫賦活剤
WO2025070280A1 (ja) * 2023-09-25 2025-04-03 オルト株式会社 ブラウティア属細菌

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014201037A2 (en) * 2013-06-10 2014-12-18 New York University Methods for manipulating immune responses by altering microbiota
WO2016086161A1 (en) * 2014-11-25 2016-06-02 Memorial Sloan-Kettering Cancer Center Intestinal microbiota and gvhd
US20160213702A1 (en) * 2015-01-26 2016-07-28 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
US20160271188A1 (en) * 2014-11-25 2016-09-22 Epiva Biosciences, Inc. Probiotic and prebiotic compositions, and methods of use thereof for treatment of gastrointestinal disorders
WO2016172657A2 (en) * 2015-04-23 2016-10-27 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
TW201710495A (zh) * 2015-06-15 2017-03-16 4D製藥研究有限公司 包含細菌菌株之組合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6368586B1 (en) 1996-01-26 2002-04-09 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
US9907755B2 (en) 2013-03-14 2018-03-06 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
WO2017035188A1 (en) * 2015-08-24 2017-03-02 Nubyiota Llc Systems and methods for treating a dysbiosis using fecal-derived bacterial populations
CN107083339B (zh) * 2017-03-01 2020-02-14 华中农业大学 防治仔猪腹泻的复合益生菌制剂及其制备方法和应用
CN111601610A (zh) * 2017-11-14 2020-08-28 伊夫罗生物科学公司 使用布劳特氏菌属菌株治疗疾病的组合物和方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014201037A2 (en) * 2013-06-10 2014-12-18 New York University Methods for manipulating immune responses by altering microbiota
WO2016086161A1 (en) * 2014-11-25 2016-06-02 Memorial Sloan-Kettering Cancer Center Intestinal microbiota and gvhd
US20160271188A1 (en) * 2014-11-25 2016-09-22 Epiva Biosciences, Inc. Probiotic and prebiotic compositions, and methods of use thereof for treatment of gastrointestinal disorders
US20160213702A1 (en) * 2015-01-26 2016-07-28 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
WO2016172657A2 (en) * 2015-04-23 2016-10-27 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
TW201710495A (zh) * 2015-06-15 2017-03-16 4D製藥研究有限公司 包含細菌菌株之組合物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KAPARAKIS-LIASKOS M 等: ""Immune modulation by bacterial outer membrane vesicles"", 《NATURE REVIEWS IMMUNOLOGY》, vol. 15, pages 375, XP055247417, DOI: 10.1038/nri3837 *
ROBERT R. JENQ 等: ""Intestinal Blautia is associated with reduced death from graft-versus-host disease"", vol. 21, no. 8, pages 1373 - 1383, XP055252327, DOI: 10.1016/j.bbmt.2015.04.016 *
贺平 等: ""Exosome及其他胞外囊泡在病原微生物中的研究进展"", 《中国病原生物学杂志》, vol. 12, no. 4, pages 384 - 389 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111712260A (zh) * 2018-01-31 2020-09-25 伊夫罗生物科学公司 使用毛螺菌科细菌治疗免疫病症的组合物和方法
CN116867502A (zh) * 2020-09-18 2023-10-10 伊夫罗生物科学公司 细菌的固体剂型
CN114225024A (zh) * 2021-12-29 2022-03-25 北京创世客生物技术有限公司 一种用于治疗疾病的益生菌药物或保健品
CN114806979A (zh) * 2022-06-29 2022-07-29 杭州师范大学附属医院(杭州市第二人民医院) 一种治疗非酒精性脂肪性肝病的益生菌复合物及其应用
CN116254198A (zh) * 2023-01-05 2023-06-13 中国科学院微生物研究所 一种布劳特氏菌及其应用
CN116254198B (zh) * 2023-01-05 2024-03-26 中国科学院微生物研究所 一种布劳特氏菌及其应用
CN116549465A (zh) * 2023-04-26 2023-08-08 复旦大学附属中山医院 Aldh2小分子激动剂在制备治疗心血管疾病及其代谢性疾病的药物中的应用
CN116549465B (zh) * 2023-04-26 2025-02-11 复旦大学附属中山医院 Aldh2小分子激动剂在制备治疗心血管疾病及其代谢性疾病的药物中的应用
CN117617181A (zh) * 2023-12-27 2024-03-01 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) 一种系统性红斑狼疮小鼠模型的构建方法和应用
CN117617181B (zh) * 2023-12-27 2025-10-28 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) 一种系统性红斑狼疮小鼠模型的构建方法和应用
CN119709558A (zh) * 2025-02-26 2025-03-28 昆明医科大学第一附属医院(云南省皮肤病医院) 布劳特氏菌emf75-02b1b及其用途
CN119709558B (zh) * 2025-02-26 2025-05-30 昆明医科大学第一附属医院(云南省皮肤病医院) 布劳特氏菌emf75-02b1b及其用途

Also Published As

Publication number Publication date
AR113881A1 (es) 2020-06-24
CN111601610A8 (zh) 2023-07-21
EP3710023A1 (en) 2020-09-23
US10702561B2 (en) 2020-07-07
JP2021502964A (ja) 2021-02-04
US10493113B2 (en) 2019-12-03
US20190216862A1 (en) 2019-07-18
WO2019099482A1 (en) 2019-05-23
US20200030389A1 (en) 2020-01-30
TW201936203A (zh) 2019-09-16

Similar Documents

Publication Publication Date Title
US10702561B2 (en) Pharmaceutical compositions comprising a Blautia strain
JP7402805B2 (ja) ベイロネラ(Veillonella)の細菌を使用して癌及び免疫障害を処置するための組成物及び方法
US20220211773A1 (en) Compositions and methods for treating immune disorders using immune modulating lactococcus bacteria strains
TWI840334B (zh) 源自普雷沃菌(prevotella)之胞外囊泡
TWI814739B (zh) 細菌胞外囊泡
CN111712260A (zh) 使用毛螺菌科细菌治疗免疫病症的组合物和方法
EP3982987A1 (en) Processed microbial extracellular vesicles
WO2019178490A1 (en) Compositions and methods for treating cancer and inflammation using klebsiella oxytoca
WO2019178487A2 (en) Compositions and methods for treating disease using klebsiella quasipneumoniae subsp. similipneumoniae
WO2019178494A1 (en) Compositions and methods for treating cancer and inflammation using tyzzerella nexilis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CI02 Correction of invention patent application
CI02 Correction of invention patent application

Correction item: Biological Conservation Information

Correct: ATCC PTA-125346 2018.10.04

Number: 35-02

Page: The title page

Volume: 36

Correction item: Biological Conservation Information

Correct: ATCC PTA-125346 2018.10.04

Number: 35-02

Volume: 36

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200828